Advertisement

Topics

Imprimis reports $5.7 million third quarter loss

14:00 EST 12 Dec 2017 | Healio

Imprimis Pharmaceuticals reported a net loss of $5.7 million, or $0.28 per share, in the third quarter of 2017 compared with a net loss of $3.9 million, or $0.29 per share, in the third quarter of 2016, according to a company press release.
Total revenues for the quarter increased from $4.9 million to $6.5 million, while ophthalmology-related revenue was up 60% to $4.9 million.
General and administrative costs decreased from $5 million to $4.5 million for the quarter.

Original Article: Imprimis reports $5.7 million third quarter loss

NEXT ARTICLE

More From BioPortfolio on "Imprimis reports $5.7 million third quarter loss"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...